Illumina, Inc. ILMN today launched the Infinium HumanCore BeadChip
family of products. With content developed in collaboration with several
leading research institutions, the customizable Infinium HumanCore and
Infinium HumanCoreExome BeadChips support cost-effective, large-scale
genotyping and screening studies such as those performed by biobanks, genome
centers, and core labs. Based on Illumina's proven Infinium assay, the
BeadChips enable genotyping of markers found across diverse populations,
making them ideal for researchers engaged in population genetics studies
around the world.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in